Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639782 · ClinicalTrials.gov registry record · NA
Prospective Randomized On-X Versus SJM Evaluation Trial
A NA study of Heart Valve Disease, sponsored by On-X Life Technologies.
- Completed
- Registry status
- NA
- Development phase
- 857
- Enrollment target
- 20
- Study locations
NCT00639782: Completed NA study of Heart Valve Disease, sponsored by On-X Life Technologies.
NCT00639782 is a NA study of Heart Valve Disease that has completed, run by On-X Life Technologies. The registered enrollment target is 857 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639782, a NA study of Heart Valve Disease, has completed, sponsored by On-X Life Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 857 participants
- Enrollment target
- 20
- Study locations
Study Summary
The study hypothesizes that rate of thromboembolic complications of the On-X prosthesis is reduced as compared to the SJM prosthesis.
Primary Outcome
Frequency of occurrence for thromboembolic events, either major or reversible, as a function of valve type.
Conditions Studied
Interventions
- DEVICE On-X Heart valve replacement
- DEVICE SJM Heart valve replacement
Study Locations (20)
Other
- Universitats-Herzzentrum Bad Krozingen - Freiburg im Breisgau
- Universitats-Herzzentrum Freiburg - Medical Center - Freiburg im Breisgau
- Universitats Klinik Jena - Jena
- Universitat Klinik Tübingen - Tübingen
British Columbia
- St. Paul's Hospital - Vancouver
- Vancouver General Hospital - Vancouver
- Victoria Heart Institute - Victoria
Missouri
- Washington University - St Louis - St Louis
- Christian Hospital Northeast - St Louis
California
- Southern California Permanente Medical Group - Los Angeles
Hawaii
- Kaiser Foundation Hospital - Honolulu
New Jersey
- Robert Wood Johnson Medical School - New Brunswick
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Virginia
- Sentara Norfolk General Hospital - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 857 participants |
| Start Date | 2003-07 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
What the finished NCT00639782 record still lists
NCT00639782 is an interventional study that assigns participants to a tested intervention. The registered 857 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Heart Valve Disease appearing as the primary indexed condition, and to 2 interventions - of which On-X Heart valve replacement is the first listed.
NCT00639782 names 20 study sites across 14 states, led by Other, British Columbia, Missouri.
Frequently Asked Questions
What is clinical trial NCT00639782 about?
NCT00639782 is a clinical study titled "Prospective Randomized On-X Versus SJM Evaluation Trial". The study hypothesizes that rate of thromboembolic complications of the On-X prosthesis is reduced as compared to the SJM prosthesis.
What is the current status of trial NCT00639782?
This trial is currently completed. It is a NA study. The enrollment target is 857 participants. The study started on 2003-07. Estimated completion is 2021-05-01.
What conditions does trial NCT00639782 study?
This clinical trial studies the following conditions: Heart Valve Disease.
What interventions are being tested in trial NCT00639782?
The interventions under investigation include: On-X Heart valve replacement (DEVICE), SJM Heart valve replacement (DEVICE).
Who is sponsoring clinical trial NCT00639782?
This trial is sponsored by On-X Life Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00639782 being conducted?
This trial has 20 study locations across California, Hawaii, Missouri, New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00639782's enrollment target sits among peer trials
857 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06231485 · 856 participants · NA
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
- NCT05108896 · 855 participants · NA
Aspiration in Acute Respiratory Failure Survivors 2
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia